Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Journal of Alzheimer'S Disease : JAD
|
April 29, 2017
A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice
Hadar Segal-Gavish, Ortal Danino, Yael Barhum, et al.
Journal of Medicinal Chemistry
|
November 25, 2010
Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors
Shay Eliahu, Joanna Lecka, Georg Reiser, et al.
Journal of Medicinal Chemistry
|
April 24, 2018
Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P<sub>α,α</sub>-Dithiophosphate Analogues
Vadim Zelikman, Julie Pelletier, Luba Simhaev, et al.
European Journal of Medicinal Chemistry
|
October 15, 2019
Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold
Molhm Nassir, Julie Pelletier, Uri Arad, et al.
Journal of Medicinal Chemistry
|
October 9, 2015
Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action
Sagit Azran, Ortal Danino, Daniel Förster, et al.
Bioorganic & Medicinal Chemistry
|
August 3, 2015
Synthesis and structure-activity relationship of uracil nucleotide derivatives towards the identification of human P2Y6 receptor antagonists
Diana Meltzer, Ophir Ethan, Guillaume Arguin, et al.
Journal of Medicinal Chemistry
|
June 28, 2014
2-Hexylthio-β,γ-CH2-ATP is an effective and selective NTPDase2 inhibitor
Irina Gillerman, Joanna Lecka, Luba Simhaev, et al.
Journal of Medicinal Chemistry
|
October 3, 2013
Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study
Joanna Lecka, Gal Ben-David, Luba Simhaev, et al.
Rheumatology (Oxford, England)
|
April 25, 2018
Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug
Ortal Danino, Shuli Svetitsky, Sarah Kenigsberg, et al.
Journal of Medicinal Chemistry
|
March 27, 2010
2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure
Shay Eliahu, Alba Martín-Gil, María Jesús Perez de Lara, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Journal of Alzheimer'S Disease : JAD
|
April 29, 2017
A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice
Hadar Segal-Gavish, Ortal Danino, Yael Barhum, et al.
Journal of Medicinal Chemistry
|
November 25, 2010
Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors
Shay Eliahu, Joanna Lecka, Georg Reiser, et al.
Journal of Medicinal Chemistry
|
April 24, 2018
Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P<sub>α,α</sub>-Dithiophosphate Analogues
Vadim Zelikman, Julie Pelletier, Luba Simhaev, et al.
European Journal of Medicinal Chemistry
|
October 15, 2019
Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold
Molhm Nassir, Julie Pelletier, Uri Arad, et al.
Journal of Medicinal Chemistry
|
October 9, 2015
Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action
Sagit Azran, Ortal Danino, Daniel Förster, et al.
Bioorganic & Medicinal Chemistry
|
August 3, 2015
Synthesis and structure-activity relationship of uracil nucleotide derivatives towards the identification of human P2Y6 receptor antagonists
Diana Meltzer, Ophir Ethan, Guillaume Arguin, et al.
Journal of Medicinal Chemistry
|
June 28, 2014
2-Hexylthio-β,γ-CH2-ATP is an effective and selective NTPDase2 inhibitor
Irina Gillerman, Joanna Lecka, Luba Simhaev, et al.
Journal of Medicinal Chemistry
|
October 3, 2013
Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study
Joanna Lecka, Gal Ben-David, Luba Simhaev, et al.
Rheumatology (Oxford, England)
|
April 25, 2018
Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug
Ortal Danino, Shuli Svetitsky, Sarah Kenigsberg, et al.
Journal of Medicinal Chemistry
|
March 27, 2010
2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure
Shay Eliahu, Alba Martín-Gil, María Jesús Perez de Lara, et al.
Page
of 8